New Castle, Pennsylvania – Luxenberg Garbett Kelly & George, P.C. ( is releasing new public guidance on the evidentiary value ...
Discover Vor BiopharmaVor Biopharma Inc.'s potential with telitacicept amid funding challenges and market risks. Click for ...
MBX Biosciences, Inc. is rated a Buy, driven by canvuparatide's once-weekly dosing advantage in hypoparathyroidism. Learn ...
An insider’s analysis of how civil procedure governs corporate conflicts, revealing why interim relief, execution, and strategy often matter more than final ...
ScotusCrim is a recurring series by Rory Little focusing on intersections between the Supreme Court and criminal law. The first “opinion of the court” for the 2025-26 term was a […] ...
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) ...
DURHAM, N.C., November 19, 2025--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo ...
Minecraft Trial Chambers have arrived as part of the Tricky Trials update, after being available to preview via Snapshots (Java) or Previews/Beta (Bedrock) beforehand. These perilous structures ...
BOSTON, Dec. 2, 2025 /PRNewswire/ -- Solu Therapeutics, a biotechnology company pioneering novel therapies to eliminate disease-driving cells in cancer, immunology, and other therapeutic areas, today ...
CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic ...
Webcast to be held Wednesday, December 3, at 8:00am ET CAMBRIDGE, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (Nasdaq: BDTX), a clinical-stage oncology company developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback